NSE: AUROPHARMA
|
BSE: 524804
1734.00
44.00
(2.60%)
1.2M
NSE+BSE Volume
NSE 18 Sep, 2026 3:28 PM (IST)
US FDA Approval
Aurobindo Pharma gets US FDA nod for Beclomethasone HFA Inhaler, targeting a $301 million market
See details